Is 4565.T up or down today?
4565.T is down 0.60% today, last at 338.26. This stock moved -0.60% versus the prior close.
4565.T · 4565.T
4565.T (4565.T) is trading at 338.26, down 0.60% on the session. Price action and momentum indicators lean constructive.
Leading the coverage: “Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026” (Yahoo Finance, 27d ago). 4565.T is -3.03% since story.
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
4565.T is down 0.60% today, last at 338.26. This stock moved -0.60% versus the prior close.
Leading the coverage: “Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026” (Yahoo Finance, 27d ago). 4565.T is -3.03% since story. Dominant story: Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress (1 source, bearish) RSI is 58 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (181 days) · Drag or scroll left for earlier dates
Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
Nxera Pharma Webinar for Financial Results Presentation - 2Q2026
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies New York Healthcare Conference 2026
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology